Development and implementation of venous thromboembolism stewardship across a hospital network

BACKGROUND Venous thromboembolism (VTE) is a leading cause of preventable death in hospital. Ensuring all hospitalized patients are assessed for VTE risk and given appropriate prophylaxis can reduce the burden of VTE on patients and the healthcare system. This is the first study to explore the effectiveness of a VTE stewardship program using electronic clinical decision support (eCDS) to provide oversight of hospital initiatives to prevent VTE. AIM To determine if a VTE stewardship program can increase risk-appropriate VTE prophylaxis, VTE risk assessment using eCDS, any documented risk assessment and risk assessment within 24 h of admission, plus reduce the incidence of hospital acquired VTE (HA-VTE). METHODS Education, daily medication chart auditing, weekly clinician performance feedback, health promotion and gamification were deployed over 6 months by two multidisciplinary VTE stewardship teams across four hospitals. Service impact was assessed through cross-sectional audits of electronic medical records every 3 months and review of HA-VTE events pre- and post-intervention. Implementation costs were calculated. RESULTS A total of 1622 patients were audited in separate cohorts at baseline, 3, 6 and 9 months. There was significant improvement in the prescription of appropriate prophylaxis (78%, 83%, 84%, and 88%, p = 0.004), VTE risk assessment using the eCDS tool (20%, 50%, 81% and 87%, p < 0.001), any documented risk assessment (71%, 82%, 95% and 93%, p < 0.001) and any documented risk assessment within 24 h of admission (54%, 56%, 65% and 63%, p = 0.001). Use of eCDS was associated with prescription of risk-appropriate VTE prophylaxis (p < 0.001). Annual incidence of HA-VTE decreased from 7.88 to 6.99 events per 10,000 discharges pre- to post-intervention (Odds Ratio (OR) 0.89, 95 %CI 0.66-1.18, p = 0.43). The cost of implementing the program across 133,078 episodes of care during the study period was AUD$108,167 (mean cost of $0.82 per patient).

[1]  Peter J Pronovost,et al.  Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma. , 2012, Archives of surgery.

[2]  Elie A Akl,et al.  Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[3]  Samuel Z Goldhaber,et al.  Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study , 2008, The Lancet.

[4]  Florence E Turrentine,et al.  Fewer thromboembolic events after implementation of a venous thromboembolism risk stratification tool. , 2018, The Journal of surgical research.

[5]  Lennart E. Nacke,et al.  From game design elements to gamefulness: defining "gamification" , 2011, MindTrek.

[6]  S. Motte,et al.  Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium , 2014, International Journal of Clinical Pharmacy.

[7]  Robert C. Amland,et al.  Computerized Clinical Decision Support to Prevent Venous Thromboembolism Among Hospitalized Patients: Proximal Outcomes from a Multiyear Quality Improvement Project , 2015, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[8]  R. Burke,et al.  Improving the adoption of an electronic clinical decision support tool and evaluating its effect on venous thromboembolism prophylaxis prescribing at a Sydney tertiary teaching hospital , 2019, Journal of Pharmacy Practice and Research.

[9]  J. Stark,et al.  A Pharmacist-Initiated Method to Improve Venous Thromboembolic Prophylaxis Rates in Medically Ill Patients , 2006 .

[10]  Charles E Mahan,et al.  Venous Thromboembolism Prevention: A Systematic Review of Methods to Improve Prophylaxis and Decrease Events in the Hospitalized Patient , 2010, Hospital practice.

[11]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[12]  S. Polinder,et al.  Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization , 2020, PloS one.

[13]  Mary K. Lovejoy,et al.  Implementation of a Mandated Venous Thromboembolism Clinical Order Set Improves Venous Thromboembolism Core Measures , 2014, Hospital practice.

[14]  W. Churchill,et al.  Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program , 2016, Journal of Thrombosis and Thrombolysis.

[15]  C. Holzmueller,et al.  Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative , 2012, BMJ : British Medical Journal.

[16]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[17]  Rebecca Tooher,et al.  A Systematic Review of Strategies to Improve Prophylaxis for Venous Thromboembolism in Hospitals , 2005, Annals of surgery.

[18]  M. Renvall,et al.  Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. , 2009, Journal of hospital medicine.

[19]  A. Panju,et al.  Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. , 2007, Thrombosis research.

[20]  A. Turpie,et al.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. , 2007, Chest.

[21]  B. Hunt.  Preventing hospital associated venous thromboembolism , 2019, BMJ.

[22]  M. Nana,et al.  Multidisciplinary, patient-centred approach to improving compliance with venous thromboembolism (VTE) prophylaxis in a district general hospital , 2020, BMJ open quality.

[23]  Yngve Falck-Ytter,et al.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[24]  Robert J. Beaulieu,et al.  Individualized Performance Feedback to Surgical Residents Improves Appropriate Venous Thromboembolism Prophylaxis Prescription and Reduces Potentially Preventable VTE: A Prospective Cohort Study , 2016, Annals of surgery.

[25]  G. Maynard,et al.  Impact of a Multicenter, Mentored Quality Collaborative on Hospital-Associated Venous Thromboembolism , 2018, Journal of hospital medicine.

[26]  G. Raskob,et al.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. , 2016, Thrombosis research.

[27]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship , 2007 .

[28]  T. Morgenthaler,et al.  Preventing acute care-associated venous thromboembolism in adult and pediatric patients across a large healthcare system. , 2016, Journal of Hospital Medicine.

[29]  P. Sykes,et al.  Prevention of venous thromboembolism amongst patients in an acute tertiary referral teaching public hospital: a best practice implementation project , 2016, International journal of evidence-based healthcare.